![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 39, 29931-29934, September 29, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Division of Cell Biology, Department of Pediatrics,
National Jewish Medical and Research Center,
Denver, Colorado 80206
A biologically active glutathione adduct of the
eicosanoid 5-oxo-eicosatetraenoic acid has been observed as a product
formed within the murine peritoneal macrophage. This five-oxo
glutathione adduct (FOG7) was structurally
characterized using electrospray tandem mass spectrometry as a 1,4 Michael addition product 5-oxo-7-glutathionyl-8,11,14-eicosatrienoic acid. FOG7 was found to be highly potent in stimulating
eosinophil as well as neutrophil chemotaxis, also capable of initiating
actin polymerization, without elevating intracellular free calcium ion concentration within either the eosinophil or polymorphonuclear leukocyte. These biological responses suggest that either
FOG7 activates a subset of receptors mediating the broader
biological activity of the parent eicosanoid
5-oxo-6,8,11,14-eicosatetraenoic acid (5-oxo-ETE) or that a
receptor not activated by 5-oxo-ETE participates in the chemotactic
activity of FOG7. The only other known biologically active
glutathione adduct has been leukotriene C4
(LTC4), another eicosanoid that exerts potent effects
through the Cys-LT receptor. The biochemical parallel between the
formation of LTC4 and FOG7 suggests an
interesting mechanism by which biologically active eicosanoids derived
from electrophilic intermediates may have unique distribution and
prolonged efficacy in vivo.
To whom correspondence should be addressed: National Jewish
Medical and Research Center, 1400 Jackson St., Denver, CO 80206. Tel.:
303-398-1849; Fax: 303-398-1694; E-mail: murphyr@njc.org.
This article has been cited by other articles:
![]() |
N. Dronadula, F. Rizvi, E. Blaskova, Q. Li, and G. N. Rao Involvement of cAMP-response element binding protein-1 in arachidonic acid-induced vascular smooth muscle cell motility J. Lipid Res., April 1, 2006; 47(4): 767 - 777. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Stamatiou, C.-C. Chan, G. Monneret, D. Ethier, J. Rokach, and W. S. Powell 5-Oxo-6,8,11,14-eicosatetraenoic Acid Stimulates the Release of the Eosinophil Survival Factor Granulocyte/Macrophage Colony-stimulating Factor from Monocytes J. Biol. Chem., July 2, 2004; 279(27): 28159 - 28164. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bowers, C. Cool, R. C. Murphy, R. M. Tuder, M. W. Hopken, S. C. Flores, and N. F. Voelkel Oxidative Stress in Severe Pulmonary Hypertension Am. J. Respir. Crit. Care Med., March 15, 2004; 169(6): 764 - 769. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zarini and R. C. Murphy Biosynthesis of 5-Oxo-6,8,11,14-eicosatetraenoic Acid from 5-Hydroperoxyeicosatetraenoic Acid in the Murine Macrophage J. Biol. Chem., March 21, 2003; 278(13): 11190 - 11196. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Hevko and R. C. Murphy Formation of Murine Macrophage-derived 5-Oxo-7-glutathionyl-8,11,14-eicosatrienoic acid (FOG7) Is Catalyzed by Leukotriene C4 Synthase J. Biol. Chem., February 22, 2002; 277(9): 7037 - 7043. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Hevko, R. C. Bowers, and R. C. Murphy Synthesis of 5-Oxo-6,8,11,14-eicosatetraenoic Acid and Identification of Novel omega -Oxidized Metabolites in the Mouse Macrophage J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 293 - 305. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |